Research is ongoing to explore ways to restore the function of defective FANCJ. Gene therapy and small molecule drugs that can enhance the DNA repair capacity of cells are areas of active investigation. While these approaches are still in the experimental stages, they hold promise for improving outcomes in patients with FANCJ-related cancers.
